Table 1 Baseline characteristics of patients
Patient | Age | Sex | Disease type | Previous treatment | Stool routine | ESR (mm/h) | CRP (mg/l) | Stool frequency | Rectal bleeding | UC duration |
|---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | 65 | Female | Moderate | 5-ASA | (+) | 115 | 20 | 8–10 | None | 2 y |
Patient 2 | 58 | Female | Severe | Glucocorticoid;5-ASA | (+) | 20 | 1.1 | 5–20 | Obvious blood | 2 y |
Patient 3 | 46 | Male | Severe | 5-ASA | (+) | 25 | 8.6 | 10 | Mostly blood | 3 mo |
Patient 4 | 52 | Female | Moderate | 5-ASA | (+) | 22 | 1 | 4–5 | Obvious blood | 5 y |
Patient 5 | 41 | Male | Moderate | Traditional Chinese medicine | (+) | 7 | 1.2 | 3–4 | Obvious blood | 1 y |
Patient 6 | 49 | Male | Severe | Glucocorticoid; 5-ASA | (+) | 18 | 7.63 | 9–10 | Obvious blood | 10+ y |
Patient 7 | 53 | Female | Severe | Glucocorticoid; 5-ASA | (+) | 36 | 9.8 | 8–10 | Mostly blood | 9 y |
Patient 8 | 49 | Male | Moderate | 5-ASA | (+) | 6 | – | 4–5 | Obvious blood | 4 mo |
Patient 9 | 43 | Male | Severe | 5-ASA | (+) | 21 | 12.6 | 4–5 | Mostly blood | 10 + y |
Patient 10 | 52 | Male | Severe | Glucocorticoid;5-ASA | (+) | 3.11 | <0.1 | >10 | Obvious blood | 6 y |
Patient 11 | 48 | Male | Moderate | 5-ASA | (+) | 37 | 45.7 | 6–8 | Obvious blood | 1 y |
Patient 12 | 58 | Female | Severe | Glucocorticoid;5-ASA | (+) | 48 | 36.1 | >10 | Mostly blood | 20 y |